UBS AM’s MapLight Therapeutics MPLT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPLT
UBS AM's MPLT Position: Q3 2026 in Review
UBS AM opened a new position in MapLight Therapeutics (MPLT) in Q3 2026: 42 shares worth $428. The stake represents ﹤0.01% of the portfolio and ranks #4184 among its holdings.
73 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.
- UBS AM held 42 shares of MapLight Therapeutics worth $428 as of Q3 2026.
- MapLight Therapeutics was a new UBS AM position in Q3 2026.
- MapLight Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4184 holding.
- 73 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.